Several drugs inhibiting HIF-1α protein synthesis such as Topotecan, CRLX101, a nanoparticle conjugate containing the payload camptothecin (CPT) are undergoing clinical investigation for HIF-overexpressing cancers (NCT01652079). This evidence concerns the gene HIF1A and cancer.